Sunny Balwani is a former president and chief operating officer of Theranos, a now-defunct health technology company. He joined the company in 2009 and played a key role in its operations and expansion.
In 2018, Balwani was indicted on nine counts of wire fraud and two counts of conspiracy to commit wire fraud. He has pleaded not guilty and is currently facing legal battles related to his involvement in the Theranos scandal.
While the exact net worth of Sunny Balwani is not publicly known, it is speculated to be in the millions. His wealth was largely tied to his stake in Theranos, which was once valued at $9 billion before its downfall.
As of now, Balwani's financial status is uncertain due to the ongoing legal proceedings. It is reported that he has made investments in various start-ups and technology companies since his departure from Theranos.
Sunny Balwani is currently facing legal battles related to his involvement in the Theranos scandal. He has pleaded not guilty to the charges against him and is awaiting trial.
The downfall of Theranos and the legal troubles that followed have likely had a significant impact on Sunny Balwani's net worth. His wealth was largely tied to his stake in the company, which is now virtually worthless.
After leaving Theranos, Sunny Balwani has reportedly made investments in various start-ups and technology companies. However, his current level of involvement in the tech industry is not widely known.
